Aebersold Sarah's Form 4 filing
Biolife Solutions Inc (BLFS) · filed Apr 23, 2024
- Accession no.
- 0001628280-24-017499
- Filed
- Apr 23, 2024
- Trade date
- Apr 18-22, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $12.1K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aebersold SarahCIK 0001837756 | Officer (Chief Human Resources Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2024 | Common Stock | SSaleDisposed | −348 | $15.31 | −$5,327.88 | 65,495 | Direct | |
| Apr 22, 2024 | Common Stock | SSaleDisposed | −410 | $16.50 | −$6,765 | 65,085 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.